Bumper Offer - Urjas oil Just @ Rs. 1
Dubatran, a prescription drug, is manufactured in various forms such as Capsule, Tablet, Injection. It is typically used for the treatment of Bleeding. The alternative uses of Dubatran have also been explained below.
The optimal dosage of Dubatran is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Dubatran as well, which are listed below. These side effects of Dubatran are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Dubatran is Moderate for pregnant women and Safe for women who are breastfeeding. In addition, Dubatran's effects on the liver, heart and kidney are discussed below in the Dubatran related warnings section.
Dubatran is not recommended if you suffer from certain medical conditions as it can have adverse effects. Blood Cancer, Colour Blindness, Allergy are examples of such conditions.
Besides this, Dubatran may also have severe interaction with some medicines. A complete list of these interactions is given below.
In addition to the above precautions for Dubatran, it is important to know that it is safe while driving, and is habit-forming.
Dubatran is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult(Female) |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Dubatran is used -
Severe
Moderate
Mild
Is the use of Dubatran safe for pregnant women?
Dubatran can have harmful effects in pregnant women. If you experience any discomfort after using Dubatran, then discontinue the use and take your doctor's advice.
Is the use of Dubatran safe during breastfeeding?
Dubatran is completely safe for breastfeeding women.
What is the effect of Dubatran on the Kidneys?
There may be some adverse effects on kidney after taking Dubatran. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Dubatran on the Liver?
Very few cases of side effects of Dubatran on the liver have been reported.
What is the effect of Dubatran on the Heart?
You may experience side effects on your heart after taking Dubatran. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Dubatran should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Dubatran unless your doctor advises you to do so -
Is this Dubatran habit forming or addictive?
Dubatran is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Dubatran does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Yes, but consume Dubatran only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Dubatran for mental disorders.
Interaction between Food and Dubatran
There isn't any research available on the side effects of taking Dubatran with food.
Interaction between Alcohol and Dubatran
No research has been done on this till date. Therefore, it is not known what the effect of taking Dubatran with alcohol will be.
Dubatran is available in the form of an injection and tablet. Injection must be taken under the supervision of a doctor. The tablet should be taken orally or by mouth. Depending upon your condition, your doctor will suggest you a dosing schedule. It is important that you stick to this schedule. It can be taken with or without food. It should be taken at exactly the same time every day so that you don't miss the dose. If your bleeding doesn't reduce or gets worse, call your doctor immediately.
Yes, Dubatran may cause allergy in rare cases. The symptoms could be rash, itching, extreme dizziness, swelling of the tongue, throat, and face, difficulty in breathing, etc. If you experience any of these symptoms, discontinue using Dubatran and talk to your doctor immediately.
Dubatran is the brand name for tranexamic acid. It belongs to class drugs known as antifibrinolytics. It is available in the form of injection and tablets. It is used to prevent or reduce hemorrhage in patients struggling with hemophilia, to lessen the need for a replacement therapy during and after a tooth extraction procedure, and for managing excessive bleeding during surgery, trauma and menstruation.
No, Dubatran is not a steroid. It is an anti-fibrinolytic agent that stops the process of fibrinolysis, preventing blood loss.
No, Dubatran doesn't cause anxiety. Anxiety is a group of mental disorder characterized by excessive fear and feels nervousness. It has not been reported by the patients who are taking it. However, if you experience anxiety after taking this drug then it might be due to some other medical condition. You are advised to discuss it with your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 628-629
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lysteda™ (tranexamic acid)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cyklokapron® (tranexamic acid)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 628-629
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lysteda™ (tranexamic acid)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cyklokapron® (tranexamic acid)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 628-629
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lysteda™ (tranexamic acid)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cyklokapron® (tranexamic acid)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 385
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 623-624
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pradaxa® (dabigatran etexilate mesylate)